biostudies-literatureUnknown19(1)Lai M<h4>Introduction</h4>Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity.<h4>Case presentation</h4>We present a case of a 30-year-old woman who developed drug-induced liver injury (DILI) to liraglutide, confirmed on histology, with resolution on cessation of liraglutide over 6 months.<h4>Conclusion</h4>DILI secondary to liraglutide appears to be a rare but an important adverse effect.Case reports in gastroenterology653-658https://www.ebi.ac.uk/biostudies/studies/S-EPMC12503594biostudies-literatureLiraglutide-Induced Liver Injury: A Case Report and Review.PMC12503594Nicoll AHosking PSawhney RLai MfalseLiraglutide-Induced Liver Injury: A Case Report and Review.<h4>Introduction</h4>Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity.<h4>Case presentation</h4>We present a case of a 30-year-old woman who developed drug-induced liver injury (DILI) to liraglutide, confirmed on histology, with resolution on cessation of liraglutide over 6 months.<h4>Conclusion</h4>DILI secondary to liraglutide appears to be a rare but an important adverse effect.2025-01-01T00:00:00Z2025 Jan-Dec2026-06-04T07:40:01.988Z2026-06-01T03:06:14.576ZS-EPMC125035944106454710.1159/000547634